Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,481 across all filing types
Latest filing 2023-10-12 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from Bissera Lazarova under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.
Director's Dealing Classification · 100% confidence The document details a transaction involving a 'person discharging managerial responsibilities' (Bissera Lazarova, a member of the Board of directors of Sopharma AD) concerning the acquisition of shares ('Certified share account from conditional capital increase through the exercise of warrants'). This structure, focusing on insider transactions, position, and specific transaction details (price/volume), is characteristic of regulatory filings mandated under market abuse regulations (like MAR in the EU, referenced by Regulation 596/2014). This directly corresponds to the definition of Director's Dealing (DIRS), which covers personal share transactions by directors and executives.
2023-10-12 English
Notification from Rositsa Doneva under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities' (Rositsa Doneva) concerning shares of 'Sopharma AD'. It specifies the nature of the transaction as related to the 'exercise of warrants from issue' and reports the price and volume. This structure is characteristic of mandatory insider transaction reporting, specifically under EU regulations (Regulation 596/2014 is referenced). Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate classification for reports of personal share transactions by directors and executives (insider trades). The document is not a full annual report (10-K), an earnings release (ER), or a general proxy statement (DEF 14A/PSI).
2023-10-12 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.
Director's Dealing Classification · 100% confidence The document details a transaction involving a person discharging managerial responsibilities ('Ognian Donev') concerning shares of the issuer ('Sopharma AD'). Specifically, it outlines the nature of the transaction ('Certified share account from conditional capital increase through the exercise of warrants') and provides details on price, volume, and date (10.10.2023). This structure is characteristic of insider trading disclosures or director's dealing reports, which mandate reporting personal share transactions by executives. Comparing this to the definitions, 'Director's Dealing (Code: DIRS)' is the most appropriate classification.
2023-10-12 English
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 10 October 2023.
Director's Dealing Classification · 100% confidence The document is explicitly titled "Current report: 185/ 11.10.2023 NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". This directly indicates a report concerning transactions by persons discharging managerial responsibilities (insiders) or persons closely associated with them, as mandated by Article 19 of the EU Market Abuse Regulation (MAR). This aligns perfectly with the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by directors and executives (insider trades). The content details the person, the issuer, and the transaction (price and volume of shares).
2023-10-11 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 10 October 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a person discharging managerial responsibilities ('Donev Investments Holding AD' related to 'Sopharma AD') and specifies the nature of the transaction ('Certified share account from conditional capital increase through the exercise of warrants'). It includes details like the financial instrument (Shares, ISIN), price, volume, date (10.10.2023), and place of transaction. This structure is characteristic of insider transaction reporting, specifically mandated by regulations like MAR (Market Abuse Regulation) in the EU, which requires reporting of transactions by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate classification for reporting personal share transactions by directors and executives.
2023-10-11 English
New capital of "Sopharma" AD entered in the Commercial Register
Capital/Financing Update Classification · 98% confidence The document is a 'Current report' announcing a change in the company's capital structure following the exercise of warrants, resulting in a new capital amount being registered in the Commercial Register. This directly relates to changes in the company's capital structure or financing activities. The most appropriate category is 'Capital/Financing Update' (CAP). The document is short and acts as a notification of a completed capital event.
2023-10-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.